Evidence for Neuroprotective Effect of Sulbutiamine against Oxygen-Glucose Deprivation in Rat Hippocampal CA1 Pyramidal Neurons
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kwag, Jeehyun | - |
dc.contributor.author | Majid, Aman Shah Abdul | - |
dc.contributor.author | Kang, Kui Dong | - |
dc.date.accessioned | 2021-09-07T06:38:35Z | - |
dc.date.available | 2021-09-07T06:38:35Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2011-11 | - |
dc.identifier.issn | 0918-6158 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/111246 | - |
dc.description.abstract | Hippocampus is one of the earliest brain regions that gets affected by ischemia, however, no pharmacological therapy exists yet that can fully counteract the ischemic damage. Here we study the effect of sulbutiamine, a synthetic thiamine analogue that can cross the blood-brain barrier easily, on hippocampal neurons under an in vitro model of ischemia, oxygen-glucose deprivation (OGD). We find that exposure to OGD in the presence of sulbutiamine significantly increases neuronal viability and enhances electrophysiological properties such as excitatory synaptic transmissions and intrinsic neuronal membrane input resistance in a concentration-dependent manner. Overall, here we report, for the first time, the neuroprotective evidence of sulbutiamine on hippocampal CA1 pyramidal neurons under OGD, which may have beneficial implications as a possible therapeutic agent/substance against ischemic insult. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PHARMACEUTICAL SOC JAPAN | - |
dc.subject | CELL-DEATH | - |
dc.subject | SELECTIVE VULNERABILITY | - |
dc.subject | BRAIN NEURONS | - |
dc.subject | IN-VITRO | - |
dc.subject | ISCHEMIA | - |
dc.subject | THIAMINE | - |
dc.subject | SLICES | - |
dc.subject | EXCITABILITY | - |
dc.subject | INVOLVEMENT | - |
dc.subject | IMPAIRMENT | - |
dc.title | Evidence for Neuroprotective Effect of Sulbutiamine against Oxygen-Glucose Deprivation in Rat Hippocampal CA1 Pyramidal Neurons | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kwag, Jeehyun | - |
dc.identifier.scopusid | 2-s2.0-81455128689 | - |
dc.identifier.wosid | 000296270900018 | - |
dc.identifier.bibliographicCitation | BIOLOGICAL & PHARMACEUTICAL BULLETIN, v.34, no.11, pp.1759 - 1764 | - |
dc.relation.isPartOf | BIOLOGICAL & PHARMACEUTICAL BULLETIN | - |
dc.citation.title | BIOLOGICAL & PHARMACEUTICAL BULLETIN | - |
dc.citation.volume | 34 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 1759 | - |
dc.citation.endPage | 1764 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | CELL-DEATH | - |
dc.subject.keywordPlus | SELECTIVE VULNERABILITY | - |
dc.subject.keywordPlus | BRAIN NEURONS | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | ISCHEMIA | - |
dc.subject.keywordPlus | THIAMINE | - |
dc.subject.keywordPlus | SLICES | - |
dc.subject.keywordPlus | EXCITABILITY | - |
dc.subject.keywordPlus | INVOLVEMENT | - |
dc.subject.keywordPlus | IMPAIRMENT | - |
dc.subject.keywordAuthor | sulbutiamine | - |
dc.subject.keywordAuthor | oxygen-glucose deprivation | - |
dc.subject.keywordAuthor | hippocampus | - |
dc.subject.keywordAuthor | neuroprotection | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.